In their invited narrative review article, Gionchetti et al (April-June issue) [1] report 6 studies in which probiotics were used for maintenance of remission in pouchitis or induction of remission in acute pouchitis. In all but one studies VSL#3 probiotic was used. In 4 studies treatment group (VSL#3 regimen was used in 3 studies) was compared to a control group 
In their invited narrative review article, Gionchetti et al (April-June issue) [1] report 6 studies in which probiotics were used for maintenance of remission in pouchitis or induction of remission in acute pouchitis. In all but one studies VSL#3 probiotic was used. In 4 studies treatment group (VSL#3 regimen was used in 3 studies) was compared to a control group [2] [3] [4] [5] . [Q1. references are missing]. The studies of VSL#3 may form a coherent group, although the duration of treatment varied between 9 and 12 months. A recent meta-analysis of probiotic efficacy for gastrointestinal diseases synthesized data of 4 studies of pouchitis treatment [6] . In this systematic review the relative risk ratio for the probiotic group was 0. (2012) 25, 371-375 1). These results are in accordance with the findings of the systematic review [6] . Statistically significant heterogeneity will be detected if the study of Kuisma (Lactobacillus rhamnosus GG was used for 3 months) is included in the meta-analysis model.
It is of interest that a case report of 2 patients suggested that another type of probiotic, Escherichia coli Nissle 917, might be beneficial for the treatment of active pouchitis and for maintenance therapy [7] .
The results of small clinical trials and anecdotal reports indicate the urgent need for large-scale, randomized, placebocontrol trials.
